CausalSentinel

Protein Dossier — VCAM1 (Vascular cell adhesion protein 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.74 0.0273 1.92e-161 Wald ratio 1 trans 0.997
Diastolic blood pressure automated reading 0.205 0.0132 1.66e-54 Wald ratio 1 trans 0.994
Non-cancer illness code self-reported: hypertension 0.214 0.0177 1.53e-33 Wald ratio 1 trans 0.994
Platelet count 21.9 2.21 3.64e-23 Wald ratio 1 trans 0.997
Haemoglobin concentration 0.273 0.0306 3.64e-19 Wald ratio 1 trans NA
Systolic blood pressure automated reading 0.115 0.0132 2.52e-18 Wald ratio 1 trans 0.993
Total cholesterol -0.171 0.0198 8.36e-18 Wald ratio 1 trans 0.998
Packed cell volume 0.779 0.0949 2.34e-16 Wald ratio 1 trans NA
Red blood cell count 0.0858 0.0118 3.52e-13 Wald ratio 1 trans NA
HDL cholesterol -0.138 0.0193 7.68e-13 Wald ratio 1 trans 0.997
LDL cholesterol -0.144 0.0204 1.76e-12 Wald ratio 1 trans 0.997
Non-cancer illness code self-reported: psoriasis 0.501 0.074 1.36e-11 Wald ratio 1 trans 0.992
…and 130 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2967_8_1 VCAM-1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

63 association rows across 39 traits (57 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Hematological traits (multi-trait analysis) 2e-78 rs6684679 2 GCST90838669 no MR -> candidate analysis
Lymphocyte count (UKB data field 30120) 5e-49 rs2148404 2 GCST90468082 no MR -> candidate analysis
Circulating VCAM1 levels 1e-42 rs139561173 2 GCST90860455 no MR -> candidate analysis
VCAM1 protein levels 7e-39 rs12240047 2 GCST90471031 no MR -> candidate analysis
Lymphocyte count 1e-38 rs12088882 4 GCST90085815 no MR -> candidate analysis
Platelet-to-lymphocyte ratio 1e-35 rs12047102 1 GCST90056184 no MR -> candidate analysis
monocyte (absolute count, mean, inv-norm transformed) 1e-31 rs78453488 1 GCST90475502 no MR -> candidate analysis
Monocyte count 3e-30 rs71660930 3 GCST90002393 no MR -> candidate analysis
lymphocyte (absolute count, maximum, inv-norm transformed) 1e-29 rs1409425 1 GCST90479663 no MR -> candidate analysis
lymphocyte (absolute count, mean, inv-norm transformed) 2e-28 rs11166512 1 GCST90479664 no MR -> candidate analysis
Monocyte count (UKB data field 30130) 7e-26 rs71660930 1 GCST90468090 no MR -> candidate analysis
Lymphocyte percentage (UKB data field 30180) 6e-24 rs10875333 1 GCST90468083 no MR -> candidate analysis
…and 27 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1289 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
open-angle glaucoma 0.55 common-variant locus no MR -> candidate analysis
glaucoma 0.459 common-variant locus MR: beta=-0.231, p=0.0954 (trans)
Crohn disease 0.346 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Vascular cell adhesion protein 1)
gnomAD constraint pLI=5e-09, LOEUF=0.833 — LoF-tolerant
GWAS Catalog 55 unique SNPs / 110 rows
ClinVar 114 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance